News

Study findings could help researchers better tailor their drug-delivery particles to specific types of cancer, or design new particles that take advantage of the biological features of particular types of cancer cells.

Researchers have developed a new blood test that provides unprecedented insight into a patient’s cancer make-up, potentially allowing doctors to better select treatment options that will improve outcomes.

Charged nanoparticles could be used to deliver cancer vaccines directly to the tumor, enabling a localized immune response against the tumor.

Patient-derived organoids could help direct pancreatic cancer treatment strategy, as they can predict how the tumor will respond to chemotherapy before surgery.

After many studies, The International Agency for Research on Cancer has classified occupational exposure as a firefighter as carcinogenic.

Researchers have identified a mechanism that allows cancer cells to multiply indefinitely in the body by activating a gene to protect their telomeres. This discovery aims to guide the development of cancer-specific drugs with fewer side effects.

A new study has shown that a key genetic mutation that occurs early on in cancer alters RNA “dark matter” and causes the release of previously unknown RNA biomarkers.

Researchers have demonstrated how machine learning models can reveal interactions between a patient's gut microbiome and their response to immunotherapy, in findings that may ultimately improve cancer patient outcomes.

A team of researchers have shown how non-coding "junk" DNA can impair DNA replication and repair, potentially enabling mutations to accumulate, leading to cancer.

University of Zurich researchers found that single cells make decisions much more autonomously than previously thought.